proteins thought to act as transcriptional activators. Also here
genetics in pediatric leukemia, accounting for less than 0.05% prevalence. [4] [5] [6] [7] the der(21) partner only of t(12;21)(p13;q22), probably resulting
Recently, the t(12;21)(p13;q22) breakpoint was cloned and To investigate the frequency of TEL-AML1 rearrangements, Acquired chromosomal translocations have long been recogseveral groups analyzed large panels of children with acute nized in association with defined subtypes of leukemias. 1 lymphoblastic leukemia (ALL) or acute myeloid leukemia Identification of these chromosomal abnormalities has aided (AML) using Southern blotting, FISH and reverse-transcriptase polymerase chain reaction (RT-PCR) with frequencies as detailed in Table 1 . 3, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Only very few adult ALL cases were found to carry the TEL-AML1 fusion ( hofen, Germany). Freedom of mycoplasma contamination was determined after thawing the cell lines by cultivation on agar and by frequent DAPI staining. The cell counts and viabilities were examined by trypan blue (Sigma) dye exclusion. Cells were harvested for RNA isolation in their logIt was further noted that the TEL-AML1 fusion is accompanied in many cases by loss or deletion of the residual (nonarithmic growth phase and with viabilities of more than 90%. Cell pellets were stored frozen at −20°C or were further protranslocated) TEL allele (=loss of heterozygosity, LOH); however, none of the patients with TEL LOH had mutations in the cessed immediately. residual TEL allele, suggesting that TEL is not a classical tumor suppressor gene 3, 9, 16, 17, [26] [27] [28] -the tight association between loss of one allele and rearrangement of the other in TEL-AML1
Reverse transcription-polymerase chain reaction (RT-PCR) suggesting a novel tumorigenic mechanism. Co-immunoprecipitation experiments demonstrated that TEL-AML1 formed homodimers in vitro, and heterodimerized with the normal Total RNA was isolated from cell pellets using standard guanidinium thiocyanate and ultracentrifugation methods. Five TEL protein when the two proteins were expressed together. 16 TEL-AML1 transcripts were never found associated with any micrograms of the total RNA were used for the synthesis of first strand cDNA applying a reverse transcriptase preamplifiother fusion transcripts or typical cytogenetic translocation.
20, 22 Finally, TEL-AML1-containing leukemic children cation kit (SuperScript; Gibco BRL). The reverse transcription was carried out with 50 ng of random hexamers in a final volappeared to have a better treatment outcome when compared to the other B-lineage cases. 3, 15, 16 However, one study found ume of 20l RT buffer (containing 20 mm Tris-HCl of pH 8.4, 50 mm KCl, 1.5 mm MgCl 2 , 0.1 mg/ml bovine serum albumin). a slightly higher incidence of the TEL-AML1 fusion in relapsed B-lineage ALL cases when compared with the untreated The mixture was incubated at 70°C for 10 min; 200 U of Moloney murine leukemia virus reverse transcriptase and 1 ml cases. 25 From these studies, it can be concluded that (1) TEL-AML1 of 10 mm dNTP mix were added to the reaction and incubated at 42°C for 50 min. The reaction was stopped by heating to is the most common gene rearrangement in childhood ALL discovered so far, despite the t(12;21) not being evident cyto-90°C for 5 min and then quickly chilled on ice. After brief centrifugation, 2 U of RNase H was added to the reaction mixgenetically; this finding may have implications for rapid diagnosis and minimal residual detection. (2) 12p deletions and ture and incubated for 20 min at 37°C. Two microliters of the first strand cDNA (corresponding to 0.5 g of RNA) were TEL LOH subsequent to the t(12;21) are likely to represent permissive events, possibly unmasking the activity of the TELdiluted with PCR buffer (10 × 500 mm KCl, 15 mm MgCl 2 , 100 mm Tris-HCl pH 8.8, 0.8% Nonidet P40) containing AML1 product and providing a further proliferative advantage to leukemic cells. (3) The TEL-AML1 fusion identifies a sub-20 pmol of each upstream and downstream primer, 10 nmol of dNTP mix and 1.25 U of Taq DNA polymerase (MBI Fergroup of pediatric ALL patients with an excellent prognosis. Finally, (4) the AML1 transcription factor is clearly a frequent mentas, St Leon-Rot, Germany) for the PCR reaction. To detect the TEL-AML1 fusion product the primers used were sense target of aberrations in both pediatric ALL as well as in de novo AML. TEL969 (5′-GAACCACATCATGGTCTCTG-3′) and antisense NAML1 (5′-AGCGGCAACGCCTCGCTCAT-3′). 8, 17 For the Continuous cell lines provide permanent sources of material for researchers in several areas, but may be of particular interreciprocal product AML1-TEL, the primers sense PG4 (5′-GGAGGAAGCGATGGCTTCAGACAGC-3′) and antisense est for studies on the molecular changes involving the recurrent breakpoints. In the event that no adequate cell line exists, NTEL (5′-AGCGGCAACGCCTCGCTCAT-3′) were employed.
To determine the quality of the RNA, the RT reaction and the investigators are restricted to using the limited amount of material available from patient samples. In the present study, PCR amplification, the following primers were used to amplify ␤-actin: sense F-ACTIN (5′-ATGGATGATGATATCGCCGCGwe attempted to define the frequency of the t(12;21) in a series of continuous leukemia cell lines derived from patients with 3′) and antisense R-ACTIN (5′-CTAGAAGCATTTGCGGTG-GAC-3′). The PCR reactions were performed with a DNA therearly B-lineage ALL pinpointing cell lines with this unique chimeric mRNA transcript.
mal cycler (Perkin Elmer Cetus, Heidelberg, Germany) under the following conditions: denaturation for 7 min at 95°C; 3 The hybridization was carried out overnight at 42°C. The detection was performed using an alkaline phosphatase-conmin at 75°C and addition of the Taq polymerase to perform a hot-start PCR; 2 min at 60°C and 10 min at 72°C for one jugated anti-Dig antibody and the substrate solution CSPD according to the recommendations of the manufacturer cycle. The amplification was carried out in 35 cycles of 30 s at 94°C, 30 s at 60°C and 60 s at 72°C with 2 s of extension (Boehringer Mannheim, Mannheim, Germany). time for each cycle. Nine microliters of the reaction mix were electrophoresed on an ethidium bromide-stained 1.4% agarose gel, observed under UV-light and blotted with 20 × SSC Cytogenetic analysis onto nylon filters (Gene Screen; DuPont, Bad Homburg, Germany) using standard methods. Digoxigenin-labeled oliFor conventional cytogenetic analysis, standard procedures were used throughout. Briefly, metaphase cells were arrested gonucleotides (TEL-AML1: 5′-AGAATAGCAGAATGCATACT-3′;
AML1-TEL: 5′-TTCATGAGAGACTGTAGACTG-3′) from growing cell cultures of REH by colcemid blockade (0.1 m for 3.5 h) and swollen for 7 min in a hypotonic solwere used for the detection of the amplification products. 17 ution comprising 0.075 m KCl and 0.9% Na-citrate (1:1). After centrifugation, cells were fixed in ice-cold methanol/acetic acid (3:1) and refrigerated overnight. After two washes in fixative, suspensions were dropped on to chilled, pre-cleaned microscope slides. Trypsin G-banding was performed on slides aged 11 days. Fluorescence in situ hybridization (FISH) was performed using 10-day-old slides, whole chromosome painting probes being obtained from Cambio (Cambridge, UK): chr 3, 4, 5, 12, 16, 21 labelled with biotin, and chr 4, 12 and 21 labelled with fluorescein isothiocyanate (FITC). A probe specific for the telomere on chromosome 12q (D12S399, D12Z5) labelled with digoxigenin was purchased from Appligene-Oncor (Heidelberg, Germany). Commercial probes were hybridized and washed according to manufacturers' instructions. Cosmid clones covering exons 1 (179A6) and 8 (148B6) of TEL (donated by Prof P Marynen, Leuven, Belgium) 30 were contrastingly labelled with digoxigenin-11-dUTP and biotin-16-ATP by nick translation. For the cosmid probes FISH was performed using probe DNA at a concentration of 4 ng/l with 100-fold excess of Cot-1 DNA (Boehringer Mannheim) in 2 × SSC, 10% dextran sulphate, 50% deionized formamide (Sigma). In all cases standard chromosome slide preparations were denatured (by incubation in 70% formamide, 2 × SSC, pH 7.0, at 74°C for 2 min), and then dehydrated in an ethanol series. After denaturing and prehybridizing probe mixtures (72°C for 5 min and 37°C for 30 min), hybridizations were performed over 48 h at 42°C in a moist chamber. Standard 'sandwich' detection was used to visualize biotin (avidin-Texas Red) and FITC (anti-FITC). Digoxigenin was visualized using a murine monoclonal antibody raised against digoxin, haptenized with FITC (Sigma). Slides were examined using a Zeiss Axioplan photomicroscope (Zeiss, Oberkochen, Germany) configured to a Cytoscan 3 image analysis system (Applied Imaging, Warrington, UK). Sequentially superimposed photographic FISH images were recorded on Kodak Ektachrome 400 using a triple bandpass filter (DAPI/FITC/Texas Red) (AHF, Tü bingen, Germany) followed by FITC alone (Zeiss).
Results and discussion

Figure 1
Identification of TEL-AML1 fusion by RT-PCR. RNAs
RT-PCR analysis was performed on mRNA specimens from 34 derived from three positive patients and from three early B-lineage human continuous leukemia cell lines derived from 31 ALL cell lines were used in an RT-PCR reaction with TEL-and AML1-specific primers. Aliquots of the amplification products were separpatients ( Table 2 ). The specificity of the PCR products was ing data. The cell lines were assigned to three different categories based on their origin from early B-lineage ALLs in children, from early B-lineage ALLs in adults, or from other TEL969-NTEL or NAML1-PG4 primers showed that the nonrearranged AML1 allele was invariably expressed in cases disleukemias (ie CML in blast crisis) or B cell type non-Hodgkin's lymphomas ( Table 2) . None of the cell lines established from playing the TEL-AML1 fusion mRNA; on the other hand, while the patients were positive for the second non-rearranged TEL adults with early B-lineage ALL or from other leukemias/lymphomas showed the TEL-AML1 fusion in the mRNA, this TEL allele was not expressed by the cell line REH suggesting a deletion. RT-PCR. Out of 13 pediatric cell lines only the cell line REH carried the TEL-AML1 fusion gene (Figure 1) . While all three
The consensus karyotype of REH was found to be: 46, X, −X, del(3)(p21.3p24), der(4)(4pter→q32?16q24.3→qter), primary samples used as positive controls for the TEL-AML1 fusion mRNA detection were also positive for the AML1-TEL t(5;12) (q31.2;p13), der(12)(12qter→q2312p13→q234q-32→qter), +16, der (16) Finally, it is interesting that 9/13 childhood ALL cell lines studied here have other known recurring translocations: six involved a straightforward reciprocal exchange of material between 5q31.2 and 12p13 (Figure 2b ), neither participating cell lines with t(1;19), one cell line each with t(4;11), t(9;22) or t(11;19). To our knowledge, the TEL-AML1 fusion has not chromosome yielded signal from either TEL cosmid indicating deletion of exons 1 to 8 of the residual TEL genomic region yet been detected in patients who also have one of these common recurring translocations. So, consideration of cell lines (spanning 240 kb), possibly as a direct result of the translocation.
without these translocations increases the frequency from 1/13 to 1/4 (25%). One might speculate that the t(12;21) is one of While the absence of any TEL-AML1 fusion product in the early B-lineage ALL cell lines established from adults accords the critical events in the leukemogenesis of these cells. Two independent sets of complex chromosome rearrangewith the data on primary material, 18, 19 the low percentage (8%) of TEL-AML1-positive pediatric early B-lineage ALL cell ments are responsible for the respective rearrangement and deletion of TEL in REH: (1) TEL-AML1 fusion by formation of lines is surprising. This might be simply due to statistically random sampling of negative cell lines. Alternatively, as the der(21)t(12;21) with concomitant loss of the reciprocal AML1-TEL fusion gene due to the surrounding, complex four-way rate of success in attempts to establish leukemia cell lines is relatively low, certainly below 5% for lymphoid leukemias t(4;12;21;16) translocation; and (2) loss of the residual TEL allele by cryptic deletion accompanying translocation in the and probably closer to 1% for myeloid leukemias, 31 it is possible that the TEL-AML1 fusion product hampers further the in t(5;12). Despite their complexity, these cytogenetic mech-
Figure 2
Chromosome rearrangements involving TEL in the REH cell line. Partial karyotype shows G-banding analysis of respective sets of rearrangements involving TEL-AML1 fusion (a) and TEL deletion (b). The t(4;12;21;16)(q32;p13;q22;q24.3) translocation shown in (a) generates the der(21), but not the der(12), product of t(12;21)(p13;q13) consistent with the formation of TEL-AML1, but not AML1-TEL, mRNA detected by RT-PCR. Note the associated inversion, inv(12(p13q23). Neither partner of the t(5;12)(q31;p13) shown in (b) yielded signals from TEL cosmids showing that this translocation was accompanied by a microdeletion affecting 12p13. Thus, two respective series of complex cytogenetic events are responsible for fusion of TEL with AML1, and deletion of the residual TEL allele.
anisms in REH effect in the same combination of TEL-AML1 fusion/residual TEL deletion consistently observed in patient studies. 14, 17 It is thus likely that the rearrangements in REH arose in vivo. Thus, REH provides an insight into possible cytogenetic mechanisms underlying the paradigm of TEL rearrangement and deletion in t(12;21) seldom affordable by the more limited studies possible on primary leukemia cells.
In summary, we detected one continuous leukemia cell line, namely the pediatric early B-lineage ALL-derived line REH, that carries the t(12;21) fusion gene TEL-AML1 accompanied by deletion of the residual allele. As various continuous leukemia-lymphoma cell lines have been instrumental in the molecular study of a number of breakpoints, this cell line represents a powerful tool for the further characterization of this particular breakpoint and can also be used as a permanently available (standardizable) positive control in the PCR analysis of TEL-AML1 fusion transcripts.
